Please assess the completion status of the following clinical trial:

Trial Title: Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adolescents who completed V102_16 study and received the study vaccines as assigned in the protocol (either two doses of the MenABCWY or one dose each of MenACWY and Placebo).~Exclusion Criteria:~* Serious, acute, or chronic illnesses. Previous or suspected disease caused by N. meningitidis.~* History of any meningococcal vaccine administration other than vaccination given in the parent V102_16 protocol.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 19 Years
- Healthy Volunteers: f

Study Arms:
- MenABCWY Group (Type: EXPERIMENTAL): Subjects who received 2 doses of MenABCWY vaccine in the parent study and a 3rd dose of MenABCWY vaccine in the current study.
- MenACWY Group (Type: ACTIVE_COMPARATOR): Subjects who received 1 dose of placebo and 1 dose of MenACWY vaccine in the parent study and 1 dose of placebo in the current study.

Based on this trial design, predict the completion outcome and termination type (if applicable).